Clinical trials
Placebo Effect clinical trials
Below are recruiting placebo effect clinical trials, each written for real people, not researchers. We’re tracking 725 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06957808Recruiting
Diroximel fumarate brain health study for schizophrenia
This trial tests if a drug called diroximel fumarate can help increase a natural antioxidant (glutathione) in the brain for people with schizophrenia. It aims to see if lowering inflammation and boosting brain protection might improve symptoms.
London, Greater LondonAges 18–65 - NCT06538649RecruitingEarly Phase 1
Testing statins for Crohn's disease before and after surgery
This study tests whether taking a statin (a cholesterol-lowering medicine) before and after surgery for Crohn's disease can help improve outcomes. It's for people with a specific type of Crohn's that causes narrowing in the small intestine and who are already scheduled for surgery.
Stanford, CaliforniaAges 18–80 - NCT05835037RecruitingPhase 4
Zinc supplement study for prediabetes blood sugar control
This study tests whether taking zinc can improve how your body controls blood sugar in people with prediabetes. It may help slow the progression toward type 2 diabetes, but you would need to meet specific health and medication criteria.
Lancaster, PennsylvaniaAges 18–80 - NCT05469854RecruitingPhase 1
Study of linaprazan glurate in healthy volunteers
This study tests a new drug called linaprazan glurate in healthy adults aged 18 to 65. It looks at how the drug moves through your body and if it affects your heart rhythm.
UppsalaAges 18–65 - NCT05483465RecruitingPhase 4
NAD supplement trial for brain blood vessel health in aging
This trial studies whether taking an NAD supplement can support brain blood vessel health as people age. Participants will be tested for brain and health changes and may help researchers understand how to keep the brain’s blood vessels healthier over time.
Oklahoma City, OklahomaAges 60–85 - NCT05301608RecruitingPhase 1/Phase 2
Psilocybin study of brain activity and changing thoughts
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
Baltimore, MarylandAges 18–75 - NCT05142735Recruiting
NAC for early psychosis risk symptoms
This trial studies whether NAC (a nutrient-like supplement) can reduce symptoms in people who are at high risk for developing psychosis. It may help by testing a safer, non-standard treatment approach for early warning signs.
Toronto, OntarioAges 16–35 - NCT04576078RecruitingPhase 2
Nefopam for less pain after knee replacement surgery
This Phase 2 study tests whether oral nefopam can reduce pain after total knee replacement done with spinal anesthesia. It looks at whether this medicine works better than the usual post-surgery pain plan and how safely it can be used.
Lyon, LyonAges 18–75 - NCT06216041RecruitingPhase 1
Safety study of IMM-H014 in healthy adults
This trial tests a new drug called IMM-H014 in healthy volunteers to see if it is safe and how the body processes it. It also checks if food changes how the drug works. You may join if you are generally healthy and meet the age and weight requirements.
Changchun, JilinAges 18–45 - NCT07380412Recruiting
Supplement study for ADHD med side effects
This trial tests if a dietary supplement can help reduce common side effects of stimulant medications for ADHD, like trouble sleeping or feeling irritable. If you take a stable dose of ADHD medication and are dealing with these issues, you may be able to join.
Las Vegas, NevadaAges 18–55 - NCT06723119Recruiting
Resveratrol supplement for exercise and recovery in men
This study tests whether a daily supplement called resveratrol (found in some foods) can help active men exercise better and recover faster. You'll take either resveratrol or a placebo, follow a diet, and complete fitness tests.
Orlando, FloridaAges 18–40 - NCT07301034RecruitingPhase 3
Ziltivekimab for plaque after a heart attack
This study tests a drug called ziltivekimab to see if it can reduce fatty plaque buildup in heart arteries after a heart attack. It's for people who had a heart attack treated with a stent and have mild blockages in other arteries.
ViennaAges 18 years+ - NCT07818564RecruitingPhase 1
Psilocybin study on belief and insight in healthy adults
This study tests whether a single dose of psilocybin (a psychedelic compound) can help people update their beliefs and gain new insights. It's for healthy adults with some prior psychedelic experience, and it's a small pilot study at Brown University.
Providence, Rhode IslandAges 18 years+ - NCT07798960RecruitingPhase 2
Light therapy for diabetic foot ulcers
This study tests whether shining a special light on diabetic foot ulcers can help them heal faster. It aims to find out if the treatment is safe and effective.
Teresina, PiauíAges 18 years+ - NCT06480604Recruiting
Probiotic for yeast infection prevention
This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.
Vadodara, GujaratAges 18–50 - NCT07570472RecruitingPhase 2
CBD and sleep quality after evening exercise
This study tests whether CBD (cannabidiol, a compound from cannabis plants) can improve sleep quality after evening workouts in healthy, active adults. Researchers want to see if CBD helps you sleep better on nights when you exercise late.
Leuven, Vlaams-BrabantAges 18–40 - NCT07539298RecruitingPhase 2/Phase 3
Valsartan for Heart-Related Mitral Valve Leaking
This study tests whether a blood pressure medication called valsartan can reduce leaking in the mitral valve (a valve in your heart) caused by an enlarged left chamber. The goal is to see if this medication can improve heart function and reduce symptoms without needing surgery.
Québec, QuebecAges 18–85 - NCT06793891Recruiting
Ashwagandha extract for stress relief in women
This trial tests whether an ashwagandha supplement can help reduce high stress levels in women. If you are a woman feeling very stressed and meet the other requirements, this study might offer a natural way to manage stress.
Huntsville, AlabamaAges 30–59 - NCT07387900RecruitingPhase 2
Metformin for preventing cancer in oral leukoplakia
This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.
CairoAges 21 years+ - NCT06743802RecruitingPhase 4
Coenzyme Q10 for pain after lung surgery
This trial tests if taking coenzyme Q10 before and after thoracoscopic lung surgery can reduce pain. It may help you recover more comfortably.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT07309614RecruitingPhase 3
Dupilumab for asthma remission
This trial tests whether dupilumab, a medicine that helps reduce airway inflammation, can help people with asthma achieve remission. You may be eligible if you have asthma with high markers of inflammation and have had asthma attacks despite using your regular inhaler.
Nedlands, Western AustraliaAges 18–79 - NCT07300969RecruitingPhase 2
Testing DT-101 for adults with depression
This trial tests a new medicine called DT-101 to see if it helps people with depression. It is for adults who have had more than one depressive episode in their life.
Bentonville, ArkansasAges 18–75 - NCT07271576Recruiting
Phycocyanin study for liver fibrosis and cirrhosis
This trial tests if phycocyanin (a natural blue pigment from spirulina) can help protect the liver and slow damage from fibrosis or cirrhosis. It may be an option if you have stable liver disease and are looking for supportive therapy.
HangzhouAges 18–75 - NCT07234890RecruitingPhase 2
Testing AV-001 to protect the brain during hemodialysis
This study tests a new medicine called AV-001 to see if it can protect the brain from damage caused by hemodialysis. If you qualify, you may help find a way to reduce thinking and memory problems linked to dialysis.
London, OntarioAges 18 years+
Hear when a new Placebo Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo effect?
- Yes. Clin2 currently lists 725 recruiting placebo effect studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo effect trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo effect trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.